 |
| 15-Apr-13 | Reiterated |
Barclays |
Equal Weight |
$25 → $32 |
|
| 30-Jan-13 | Reiterated |
UBS |
Buy |
$29 → $31 |
|
| 30-Jan-13 | Reiterated |
Argus |
Buy |
$28 → $32 |
|
| 22-Jan-13 | Reiterated |
Barclays |
Equal Weight |
$24 → $25 |
|
| 27-Nov-12 | Downgrade |
MKM Partners |
Buy → Neutral |
$29 → $25 |
|
| 05-Oct-12 | Reiterated |
MKM Partners |
Buy |
$27 → $29 |
|
| 01-Nov-11 | Downgrade |
Standpoint Research |
Buy → Hold |
|
|
| 07-Oct-11 | Initiated |
MKM Partners |
Buy |
$20.50 |
|
| 14-Sep-11 | Downgrade |
Barclays Capital |
Overweight → Equal Weight |
$21 → $19 |
|
| 10-Aug-11 | Upgrade |
Argus |
Hold → Buy |
$21 |
|
| 05-Aug-11 | Upgrade |
Standpoint Research |
Hold → Buy |
$21 |
|
| 14-Mar-11 | Downgrade |
Standpoint Research |
Buy → Hold |
|
|
| 03-Nov-10 | Downgrade |
Argus |
Buy → Hold |
|
|
| 21-May-10 | Initiated |
Jefferies |
Buy |
$17.80 |
|
| 16-Dec-09 | Initiated |
UBS |
Buy |
|
|
| 27-Apr-09 | Initiated |
Standpoint Research |
Buy |
$20 |
|
| 12-Feb-09 | Upgrade |
Leerink Swann |
Mkt Perform → Outperform |
|
|
| 09-Feb-09 | Upgrade |
UBS |
Neutral → Buy |
|
|
| 02-Feb-09 | Upgrade |
Credit Suisse |
Neutral → Outperform |
|
|
| 28-Jan-09 | Reiterated |
Argus |
Buy |
$20 → $19 |
|
|
|
| 23-May-13 12:59AM | Pfizer takes its shot at a vaccine for evasive superbug at Reuters |
| 22-May-13 07:48PM | Ireland says will not be U.S. 'whipping boy' on tax Reuters |
| 07:38PM | Invest in Your Pets for Less at Motley Fool |
| 07:13PM | 4 Healthcare Stock Stories For Midweek Investment Wellness at Wall St. Cheat Sheet |
| 06:28PM | Why the Dow Slumped 80 Points Today at Motley Fool |
| 06:08PM | Final Glance: Pharmaceuticals companies AP |
| 06:00PM | [video] What to Make of Bernanke's Testimony? at CNBC |
| 05:53PM | Bristol-Myers, Jazz Pharmaceuticals Lead Pharma Rally at Investor's Business Daily |
| 04:25PM | US STOCKS-Wall St falters in volatile session on Fed worries at Reuters |
| 04:08PM | Stocks Tumble Nearly 1% on Fed Tapering Fears at CNBC |
| 03:55PM | Ireland says will not be U.S. 'whipping boy' on tax Reuters |
| 03:51PM | 4 Big Drug Companies With Big Juicy Yields at Motley Fool |
| 03:46PM | [$$] Pfizer to Spin Off Remaining Zoetis Stake at The Wall Street Journal |
| 03:33PM | Talk of Tapering Sends Stocks Sharply Lower at Motley Fool |
| 03:18PM | Daily Wrap: May 22, 2013 at Forbes |
| 03:08PM | Pfizer Rises On Unusually High Volume (PFE) at TheStreet |
| 03:07PM | US STOCKS-Wall St declines as FOMC minutes raise concern over Fed tapering at Reuters |
| 03:05PM | Stocks Drop After Fed Minutes Hint at Tapering at CNBC |
| 02:33PM | How Ben Bernanke Ruined the Dow's Good Day at Motley Fool |
| 02:22PM | Pfizer Doesnt Want to Monkey Around With Animal Business at Wall St. Cheat Sheet |
| 02:10PM | Stocks Fall After Fed Minutes Hint at Tapering at CNBC |
| 02:04PM | Pfizer plans offering to pare Zoetis stake AP |
| 02:02PM | US STOCKS-Wall St little changed as investors weigh Bernanke comments at Reuters |
| 01:49PM | Stocks Lose Steam as Techs Turn Lower at CNBC |
| 01:41PM | These 3 Stocks Are Leading the Dow as QE3 Continues at Motley Fool |
| 01:30PM | Is There Growth Left in Massive Drug Stocks? at Motley Fool |
| 01:18PM | Most active New York Stock Exchange-traded stocks AP |
| 01:17PM | Midday Glance: Pharmaceuticals companies AP |
| 12:30PM | [video] FMHR's Top Three Trades at CNBC |
| 12:19PM | Pfizer Spins Off Zoetis Stake, CleanTech Lands Huge Contracts, and 3 More Hot Stocks at Wall St. Cheat Sheet |
| 12:18PM | Stocks Rise as Bernanke Eases Tapering Fears at CNBC |
| 12:18PM | Stocks Jump as Bernanke Eases Tapering Fears at CNBC |
| 12:09PM | Stocks Stage Broad Advance; Bristol-Myers Leads Medicals at Investor's Business Daily |
| 12:08PM | Wall Street rises as concern eases over Fed tapering Reuters |
| 12:00PM | JPMorgan and Friends Join Dow on Its Climb at Motley Fool |
| 11:40AM | Drugmaker Pfizer To Spin Off Rest Of Zoetis June 19 at Investor's Business Daily |
| 11:09AM | US STOCKS-Wall Street rises as concern eases over Fed tapering at Reuters |
| 11:06AM | Stocks Pull Back on Bernanke Tapering Comments at CNBC |
| 11:03AM | Need a Triple-Digit Dow Pop? Just Let Big Ben Speak at Motley Fool |
| 10:52AM | Pfizer plans offering to pare Zoetis stake AP |
| 10:51AM | Early Glance: Pharmaceuticals companies AP |
| 10:50AM | Pfizer completes spinoff of animal-health unit Zoetis; shares rise at MarketWatch |
| 10:44AM | [$$] Pfizer to Spin Off Remaining Zoetis Stake at The Wall Street Journal |
| 10:17AM | Stocks Surge on Dovish Bernanke Comments at CNBC |
| 10:01AM | Pfizer plans offering to pare Zoetis stake AP |
| 10:00AM | Dow Today: Pfizer (PFE) Leads The Day Higher, UnitedHealth Group (UNH) Lags at TheStreet |
| 09:31AM | Stocks Open Higher Ahead of Bernanke Testimony at CNBC |
| 09:19AM | Futures Up After Dudley Comments; Pfizer Rising, Staples, Carnival Falling at Barrons.com |
| 08:52AM | Pfizer to spin off Zoetis stake to shareholders Reuters |
| 08:43AM | Is Merck a Buy at These Prices? at Wall St. Cheat Sheet |
| 08:18AM | Pfizer To Sell Rest of Zoetis Animal Health Stock To Investors at Bloomberg |
| 08:14AM | BRIEF-Pfizer up in premarket after plans to unwind remaining majority stake in Zoetis at Reuters |
| 08:11AM | Pfizer plans to unwind remaining majority stake in Zoetis at Reuters |
| 08:02AM | InPlay: Pfizer announces plan for split-off of Zoetis (ZTS) Briefing.com |
| 08:02AM | Zoetis To File Registration Statement; Comments on Pfizers Split-off Plans for Remaining Interest in Zoetis Business Wire |
| 08:00AM | Pfizer Announces Plan for Split-Off of Zoetis Business Wire |
| 07:48AM | AbbVie Reaches New Highs Thanks To Humira at Seeking Alpha |
| 07:38AM | Ireland feels the heat from Apple tax row Reuters |
| 07:27AM | Futures Tick Up; Fed News on Tap at Fox Business |
| 06:40AM | Stock Market News for May 22, 2013 Zacks |
| 05:28AM | Pricing A Highly Probable Takeover Of MannKind at Seeking Alpha |
| 21-May-13 09:07PM | 1 Big Pharma Phase 3 Failure at Motley Fool |
| 08:50PM | Final Glance: Pharmaceuticals companies AP |
| 06:30PM | The Surprising Link Between ADHD and Obesity at Motley Fool |
| 05:46PM | Pfizer Stock Checkup for May at Motley Fool |
| 05:30PM | Positive Data on Novartis' Afinitor Zacks |
| 04:40PM | XenoPort Candidate Disappoints Zacks |
| 04:07PM | Stocks Climb on Dovish Fed Comments; Bernanke Up Next at CNBC |
| 03:52PM | Correction: Pfizer-Study Halted story AP |
| 03:37PM | Stocks Rally on Dovish Fed Comments at CNBC |
| 02:54PM | Stocks Rally on Dovish Fed Comments; HD Surges 3% at CNBC |
| 02:39PM | Dow Today: Pfizer (PFE) Higher Dow Today: Pfizer (PFE) Lower at TheStreet |
| 02:28PM | The Top 3 Diseases Caused by Stress at Motley Fool |
| 01:33PM | S&P Hits All-Time High on Dovish Fed Comments at CNBC |
| 01:33PM | S&P 500 Hits All-Time High on Dovish Fed Comments at CNBC |
| 01:16PM | Midday Glance: Pharmaceuticals companies AP |
| 12:22PM | Stocks Rise Ahead of Bernanke; JPM Jumps 2% at CNBC |
| 11:48AM | Stocks Little Changed Ahead of Bernanke; HD Rises 2% at CNBC |
| 11:45AM | After A Big Rally, Pfizer Might Need Some Rest at Investopedia |
| 11:33AM | Stocks Little Changed Ahead of Bernanke; HD Rises 2% at CNBC |
| 11:20AM | SAC's Martoma says U.S. impedes defense in fraud case Reuters |
| 11:07AM | JPMorgan Could Maintian Joint Chair/CEO Role, Molycorp Boosted On Favorable Report and 3 More Hot Stocks at Wall St. Cheat Sheet |
| 10:48AM | Stocks Flat Ahead of Bernanke; Techs Fall at CNBC |
| 10:36AM | Early Glance: Pharmaceuticals companies AP |
| 02:06AM | Johnson & Johnson Stock Checkup for May at Motley Fool |
| 20-May-13 06:39PM | Pfizer halts study of non-Hodgkin's lymphoma drug AP |
| 06:20PM | Love Hormone Promises Safer Births After Pfizer Flop at Bloomberg |
| 06:05PM | Final Glance: Pharmaceuticals companies AP |
| 05:47PM | Pfizer halts study of lymphoma drug unlikely to help survival at Reuters |
| 05:07PM | Can Pfizers Love Hormone Cut Down Maternal Mortality? at Wall St. Cheat Sheet |
| 05:01PM | InPlay: Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma (NHL) Due to Futility Briefing.com |
| 05:01PM | Pfizer Discontinues Phase 3 Study of Inotuzumab Ozogamicin in Relapsed or Refractory Aggressive Non-Hodgkin Lymphoma (NHL) Due to Futility Business Wire |
| 03:55PM | WASIK COLUMN-Two ways to pick your summer stock retreat at Reuters |
| 03:15PM | A New Drug Sales Model at Motley Fool |
| 03:03PM | Vitamins That Cost Pennies a Day Seen Delaying Dementia at Bloomberg |
| 02:30PM | 6 Healthy Products That Aren't at Minyanville |
| 02:00PM | The 3 Deadliest Diseases in the U.S. at Motley Fool |
| 01:17PM | Midday Glance: Pharmaceuticals companies AP |
| 12:48PM | March 2014 Options Now Available For Pfizer (PFE) at Forbes |
| 12:01PM | 1 Pioneering Device to Jump-Start the Cardiovascular Industry at Motley Fool |
|
|
| Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation therapeutic and disease areas. The company's Specialty Care and Oncology segment provides human prescription pharmaceutical products primarily prescribed by physicians for therapeutic and disease areas, such as anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines. This segment also offers human prescription pharmaceutical products addressing oncology and oncology-related illnesses. Its Established Products and Emerging Markets segment offers human prescription pharmaceutical products that have lost patent protection or marketing exclusivity in certain countries and/or regions, as well as that are sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. The company's Animal Health segment offers products and services to prevent and treat disease in livestock and companion animals, including anti-infectives, vaccines, parasiticides, medicinal feed additives, other pharmaceutical products, and other non-pharmaceutical products. Its Consumer Healthcare segment provides non-prescription products in therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| SCHULMAN AMY W | Executive Vice President | May 15 | Sale | 29.36 | 70,000 | 2,055,389 | 223,497 | May 16 08:18 PM | | READ IAN C | Chairman & CEO | May 15 | Sale | 29.39 | 69,900 | 2,054,335 | 1,061,463 | May 16 08:10 PM | | DAMELIO FRANK A | Executive Vice President | May 15 | Sale | 29.33 | 100,000 | 2,932,863 | 485,682 | May 16 07:24 PM | | Germano Geno J | Business Unit President | Mar 14 | Sale | 28.00 | 40,000 | 1,120,000 | 224,392 | Mar 14 05:54 PM | | LANKLER DOUGLAS M | Executive Vice President | Mar 13 | Sale | 28.00 | 15,000 | 420,060 | 88,523 | Mar 14 05:52 PM | | MADDALUNA ANTHONY J | Executive Vice President | Mar 08 | Sale | 28.15 | 19,000 | 534,761 | 59,424 | Mar 11 03:55 PM | | HILL CHARLES H | Executive Vice President | Mar 06 | Sale | 28.08 | 21,812 | 612,566 | 74,373 | Mar 08 10:30 AM | | BRANDICOURT OLIVIER | Business Unit President | Mar 06 | Sale | 28.14 | 113,364 | 3,189,585 | 191,076 | Mar 08 10:30 AM | | Dolsten Mikael | President R&D | Mar 06 | Sale | 28.11 | 30,582 | 859,798 | 304,921 | Mar 08 10:30 AM | | SUSMAN SALLY | Executive Vice President | Mar 06 | Sale | 28.13 | 53,196 | 1,496,403 | 198,390 | Mar 08 10:30 AM | | YOUNG JOHN D | Business Unit President | Mar 06 | Sale | 28.13 | 14,713 | 413,877 | 57,520 | Mar 08 10:29 AM | | SUSMAN SALLY | Executive Vice President | Feb 28 | Option Exercise | 22.55 | 77,362 | 1,744,513 | 282,251 | Mar 04 08:00 PM | | YOUNG JOHN D | Business Unit President | Feb 28 | Option Exercise | 22.55 | 26,871 | 605,941 | 63,898 | Mar 04 08:00 PM | | READ IAN C | Chairman & CEO | Feb 28 | Option Exercise | 22.55 | 195,985 | 4,419,462 | 1,139,869 | Mar 04 07:44 PM | | MADDALUNA ANTHONY J | Executive Vice President | Feb 28 | Option Exercise | 22.55 | 19,908 | 448,925 | 75,884 | Mar 04 07:36 PM | | OLSON LAURIE J | Executive Vice President | Feb 28 | Option Exercise | 22.55 | 13,368 | 301,448 | 40,033 | Mar 04 07:36 PM | | HILL CHARLES H | Executive Vice President | Feb 28 | Option Exercise | 22.55 | 21,924 | 494,386 | 91,817 | Mar 04 07:22 PM | | LANKLER DOUGLAS M | Executive Vice President | Feb 28 | Option Exercise | 22.55 | 14,170 | 319,534 | 113,206 | Mar 04 07:22 PM | | DAMELIO FRANK A | Executive Vice President | Feb 28 | Option Exercise | 22.55 | 195,985 | 4,419,462 | 676,472 | Mar 04 06:54 PM | | CANGIALOSI LORETTA V | Sr. Vice President, Controller | Feb 28 | Option Exercise | 22.55 | 44,650 | 1,006,858 | 218,306 | Mar 04 06:49 PM | | BRANDICOURT OLIVIER | Business Unit President | Feb 28 | Option Exercise | 22.55 | 47,189 | 1,064,112 | 299,974 | Mar 04 06:40 PM | | YOUNG JOHN D | Business Unit President | Jan 30 | Sale | 27.65 | 26,752 | 739,559 | 36,708 | Feb 01 07:45 AM | | SCHULMAN AMY W | Executive Vice President | Dec 06 | Option Exercise | 17.47 | 100,000 | 1,747,000 | 346,656 | Dec 07 02:36 PM | | SCHULMAN AMY W | Executive Vice President | Dec 06 | Sale | 25.56 | 100,000 | 2,555,930 | 246,656 | Dec 07 02:36 PM | | LANKLER DOUGLAS M | Executive Vice President | Nov 21 | Sale | 24.28 | 11,970 | 290,632 | 90,370 | Nov 21 01:07 PM | | OLSON LAURIE J | Executive Vice President | Sep 13 | Sale | 24.01 | 15,242 | 365,984 | 30,328 | Sep 14 02:13 PM |
|
|
|
|
|
|
